CoChat
Sign Up
Cited by 1,947Receptor Mechanisms and SignalingIon channel regulation and functionNeuroscience and Neuropharmacology Research

Guide to receptors and channels (GRAC), 5th edition

Open access
Alexander, SPH, Mathie, A, Peters, JA·2011·British Journal of Pharmacology
DOI 10.1111/j.1476-5381.2011.01649_1.xPMC PMC3315626
Open this paper in CoChat — free accountOpen PDF

Abstract

The Fifth Edition of the 'Guide to Receptors and Channels' is a compilation of the major pharmacological targets divided into seven sections: G protein-coupled receptors, ligand-gated ion channels, ion channels, catalytic receptors, nuclear receptors, transporters and enzymes. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside suggestions for further reading. Available alongside this publication is a portal at http://www.GuideToPharmacology.org which is produced in close association with NC-IUPHAR and allows free online access to the information presented in the Fifth Edition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2011.01649_1.x

Cites

3 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 87

  1. Kinnamon SC (2011). Taste receptor signaling -from tongues to lungs. Acta Physiol (Oxf) in press.
  2. Petersen PS et al. (2011). FASEB J in press.
  3. Barnes NM, Sharp T (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38: 1083-1152.
  4. Bureau R, Boulouard M, Dauphin F, Lezoualc'h F, Rault S (2010). Review of 5-HT4R ligands: state of art and clinical applications. Curr Top Med Chem 10: 527-553.
  5. Fink KB, Göthert M (2007). 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 59: 360-417. http://www.ncbi.nlm.nih.gov/ pubmed/18160701?ordinalpos=69&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
  6. Gershon MD (1999). Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 13: Suppl 2, 15-30.
  7. Alexander SPH, Mathie A, Peters JA 5-HT (5-Hydroxytryptamine) S19 14765381, 2011, s1, References · DOI
  8. Pluim BM, de Hon O, Staal JB, Limpens J, Kuipers H, Overbeek SE et al. (2011). b-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials. Sports Med 41: 39-57.
  9. Baker JG (2011). PLoS ONE 5(11): e15487.
  10. Croom KF, Plosker GL (2008). Irbesartan: a review of its use in hypertension and diabetic nephropathy. Drugs 68: 1543-1569.
  11. Alexander SPH, Mathie A, Peters JA Bile acid S31 14765381, 2011, s1, References · DOI
  12. Howlett AC, Reggio PH, Childers SR, Hampson RE, Ulloa NM, Deutsch DG (2011). Endocannabinoid Tone versus Constitutive Activity of Cannabinoid Receptors. Br J Pharmacol in press.
  13. Le Foll B, Gallo A, Le Strat Y, Lu L, Gorwood P (2009). Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav Pharmacol 20: 1-17.
  14. Schwartz J-C et al. (1998). Dopamine receptors. In: Girdlestone D (ed.). The IUPHAR Compendium of Receptor Characterization and Classification. IUPHAR Media: London, pp. 141-151.
  15. Bowery, N.G. (2000). Pharmacology of GABAB receptors. In: Möhler H (ed.). Handbook of Experimental Pharmacology, Pharmacology of GABA and Glycine Neurotransmission, Vol. 150. Springer: Berlin, pp 311-328.
  16. Froestl W, Mickel SW (1997). Chemistry of GABAB modulators. In: Enna SJ, Bowery NG (eds). The GABA Receptors. Humana Press: Totowa, pp. 271-296.
  17. Robichaud AJ, Engers DW, Lindsley CW, Hopkins CR (2011). Recent progress on the identification of metabotropic glutamate 4 receptor ligands and their potential utility as CNS therapeutics. Acs Chemical Neuroscience in press.
  18. Schoepp DD, Alexander SP, Beart P, Conn PJ, Lodge D, Nakanishi S et al. (2000). Metabotropic glutamate receptors. In: Watson SP, Girdlestone D (eds). IUPHAR Compendium of Receptor Characterization and Classification, 2nd edn. IUPHAR Press: London, pp. 195-208.
  19. Neale JH (2011). J Neurochem in press.
  20. McHugh D et al. (2011). Br J Pharmacol in press.
  21. Alexander SPH, Mathie A, Peters JA Lysophosphatidic acid S77 14765381, 2011, s1, References · DOI
  22. Neuropeptides B and W Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, References · DOI
  23. Alexander SPH, Mathie A, Peters JA Opioid and opioid-like S89 14765381, 2011, s1, References · DOI
  24. Kukkonen JP, Åkerman KEO (2005). In: Hypocretins. Integrators of Physi- ological Signals. Springer Verlag: pp. 221-231.
  25. Alexander SPH, Mathie A, Peters JA Parathyroid hormone and parathyroid hormone-related peptide S93 14765381, 2011, s1, References · DOI
  26. S96 Proteinase-activated Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, · DOI
  27. S100 Prokineticin Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, References · DOI
  28. S106 Sphingosine 1-phosphate Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, References · DOI
  29. S108 Trace amine-associated Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, References · DOI
  30. Douglas SA, Ohlstein EH (2000). Urotensin receptors. In: The IUPHAR Receptor Compendium of Receptor Characterization and Classification. IUPHAR Media Ltd: London, pp. 365-372.
  31. Hunt BD, Ng LL, Lambert DG (2010). A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects. Naunyn Schmiedebergs Arch Pharmacol 382: 1-31.
  32. Lescot E, Bureau R, Rault S (2008). Nonpeptide Urotensin-II receptor agonists and antagonists: review and structure-activity relationships. Peptides 29: 680-690.
  33. Peters JA, Barnes NM, Hales TG, Lummis SCR (2010). 5-HT3 receptors, introductory chapter. IUPHAR database (IUPHAR-DB), http://www.iuphar- db.org/IC/FamilyIntroductionForward?familyId=2
  34. S124 GABAA (g-aminobutyric acid) Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, · DOI
  35. Hall BJ, Ghosh A (2008). http://www.ncbi.nlm.nih.gov/pubmed/18201773?ordinalpos=25&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSumRegulation of AMPA receptor recruitment at developing synapses. Trends Neu- rosci 31: 82-89.
  36. Jane DE, Tse H-W, Skifter DA, Christie JM, Monaghan DT (2000). Glutamate receptor ion channels: activators and inhibitors In: Endo M, Kurachi Y, Mishina M (eds). Handbook of Experimental Pharmacology, Pharmacology of Ionic Channel Function: Activators and Inhibitors, Vol. 147. Springer: Berlin. pp. 415-478.
  37. S128 Glutamate (ionotropic) Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, · DOI
  38. Milstein AD, Nicoll RA (2008). http://www.ncbi.nlm.nih.gov/pubmed/18514334?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSumRegulation of AMPA receptor gating and pharmacology by TARP auxiliary subunits. Trends Pharmacol Sci 29: 333-339.
  39. Monaghan DT, Jane DE (2009). Pharmacology of NMDA Receptors. In: Van Dongen AM (ed.). Biology of the NMDA Receptor. Chapter 12. CRC Press: Boca Raton.
  40. Hernandes MS, Troncone LR (2009). Glycine as a neurotransmitter in the forebrain: a short review. J Neural Transm 116: 1551-1560.
  41. Lynch JW (2009a). Glycine receptors, introductory chapter. IUPHAR database (IUPHAR-DB), http://www.iuphar-db.org/IC/FamilyIntroduction Forward?familyId=9 Lynch JW (2009b) Native glycine receptor subtypes and their physiological roles. Neuropharmacology 56: 303-309.
  42. Gargett CE, Wiley JS (1997). Br J Pharmacol 120: 1483-1490.
  43. S140 Acid-sensing (proton-gated) ion channels (ASICs) Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, References · DOI
  44. Pexton T, Moeller-Bertram T, Schilling JM, Wallace MS (2011). Targeting voltage-gated calcium channels for the treatment of neuropathic pain: a review of drug development. Expert Opin Investig Drugs 20: 1277-1284.
  45. Williams JA, Day M, Heavner JE (2008). Ziconotide: an update and review. Expert Opin Pharmacother 9: 1575-1583.
  46. Muallem D, Vergani P (2009). Review. ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator. Philos Trans R Soc Lond B Biol Sci 364: 247-255.
  47. Riquelme G (2009). Placental chloride channels: a review. Placenta 30: 659-669.
  48. Spray DC, Dermietzel R (1996). Neuroscience Intelligence Unit: Gap Junctions in the Nervous System. Springer: New York.
  49. Loffing J, Korbmacher C (2009). Regulated sodium transport in the renal connecting tubule (CNT) via the epithelial sodium channel (ENaC). Pflugers Arch 458: 111-135. S154 Epithelial sodium channels (ENaC) Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, · DOI
  50. Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, · DOI
  51. Nardi A, Olesen SP (2008). BK channel modulators: a comprehensive review. Curr Med Chem 15: 1126-1146.
  52. Wood ML et al. (2011). Biochem. Biophys Acta. doi: 10.1016/jbb.mem. 2011.07.045 References · DOI
  53. Alexander SPH, Mathie A, Peters JA Sodium (voltage-gated) S165 14765381, 2011, s1, · DOI
  54. Birnbaumer L (2009). The TRPC class of ion channels: a critical review of their roles in slow, sustained increases in intracellular Ca 2+ concentrations. Annu Rev Pharmacol Toxicol 49: 395-426.
  55. Nilius B (ed.) (2007). TRP channels in disease. Biochem Biophys Acta 1772: 805-1032.
  56. Schmuth M, Jiang YJ, Dubrac S, Elias PM, Feingold KR (2008). Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. J Lipid Res 49: 499-509.
  57. S182 Peroxisome proliferator-activated Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, · DOI
  58. Perez E, Bourguet W, Gronemeyer H, de Lera AR (2011). Modulation of RXR function through ligand design. Biochim Biophys Acta in press. References
  59. S184 Retinoic acid, retinoid X and retinoic acid-related orphan Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, propyl-17-hydroxy-androstan-4-en-17-yl; · DOI
  60. Davis PJ, Zhou M, Davis FB, Lansing L, Mousa SA, Lin HY (2010). Mini-review: cell surface receptor for thyroid hormone and nongenomic regulation of ion fluxes in excitable cells. Physiol Behav 99: 237-239.
  61. S196 Natriuretic peptide Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, · DOI
  62. Alexander SPH, Mathie A, Peters JA Pattern recognition receptors S199 14765381, 2011, s1, · DOI
  63. Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, · DOI
  64. Alexander SPH, Mathie A, Peters JA Receptor tyrosine kinases (E.C. 2.7.1.112) S209 14765381, 2011, s1, · DOI
  65. Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, · DOI
  66. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP (2008). Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 117: 244-279.
  67. Kemp S, Theodoulou FL, Wanders RJ (2011). Mammalian peroxisomal ABC transporters: from endogenous substrates to pathology and clinical significance. Br J Pharmacol in press.
  68. Kerr ID, Haider AJ, Gelissen IC (2011). The ABCG family of membrane-associated transporters: you don't have to be big to be mighty. Br J Pharmacol in press.
  69. Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, · DOI
  70. Alexander SPH, Mathie A, Peters JA SLC34 family of sodium phosphate co-transporters S265 14765381, 2011, s1, References · DOI
  71. S272 SLC41 family of divalent cation transporters Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, References · DOI
  72. S274 SLC45 orphans Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, References · DOI
  73. Rajagopal A et al. (2008). Nature 453: 1127-1131. SLCO family of organic anion transporting polypeptides Overview: The SLCO superfamily is comprised of the organic anion transporting polypeptides (OATPs). The 11 human OATPs are divided into 6 families and ten subfamilies based on amino acid identity. These proteins are located on the plasma membrane of cells throughout the body. They have 12 TM domains and intracellular termini, with multiple putative glycosylation sites. OATPs mediate the sodium-independent uptake of a wide range of amphiphilic substrates, including many drugs and toxins. Due to the multispecificity of these proteins, this guide lists classes of substrates and inhibitors for each family member. More comprehensive lists of substrates, inhibitors, and their relative affinities may be found in the review articles listed below. Abbreviations: BSP, bromosulfophthalein; CCK-8, Cholecystokinin octapeptide; DHEAS, dehydroepiandrosterone-3-sulfate; DPDPE, [d-Pen2,d-Pen5]-Enkephalin; PGT, prostaglandin transporter Further Reading Hagenbuch B (2010). Drug uptake systems in liver and kidney: a historic perspective. Clin Pharmacol Ther 87: 39-47.
  74. S278 SLCO family of organic anion transporting polypeptides Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, · DOI
  75. Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, · DOI
  76. Alexander SPH, Mathie A, Peters JA L-Arginine turnover S285 14765381, 2011, s1, References · DOI
  77. Alexander SPH, Mathie A, Peters JA Carboxylases and decarboxylases S287 14765381, 2011, s1, · DOI
  78. Alexander SPH, Mathie A, Peters JA Eicosanoid turnover S299 14765381, 2011, s1, JZL184 (8.1, Long et al., 2009) PF3845 (6.6, Ahn et al., 2009), PF750 (6.3-7.8, Ahn et al., 2007), JNJ1661010 (7.8, Keith et al., 2008), URB597 (6.3-7.0, Wei et al., 2006), OL135 (7.4, Wei et al., 2006) URB597 (7.5-8.3, Wei et al., 2006), OL135 (7.9, Wei et al., 2006) CCP (5.3, Tsuboi et al., 2004) Many of the compounds described as inhibitors are irreversible and so potency estimates will vary with incubation time. FAAH2 is not found in rodents (Wei et al., 2006). 2AG has been reported to be hydrolysed by multiple enzyme activities from neural preparations, including ABHD6 (ENSG00000163686, Blankman et al., 2007), ABHD12 (ENSG00000100997, Blankman et al., 2007), neuropathy target esterase (PNPLA6, ENSG00000032444, Marrs et al., 2010) and carboxylesterase 1 (CES1, ENSG00000198848, Xie et al., 2010). Although these have been incom- pletely defined, WWL70 has been described to inhibit ABHD6 selectively with a pIC50 value of 7.2 (Li et al., 2007). · DOI
  79. Savinainen JR, Saario SM, Laitinen JT (2011). The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. Acta Physiol (Oxf) in press.
  80. Alexander SPH, Mathie A, Peters JA Endocannabinoid turnover S301 14765381, 2011, s1, · DOI
  81. Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, · DOI
  82. Martelli A, Testai L, Breschi MC, Blandizzi C, Virdis A, Taddei S et al. (2010). Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev in press.
  83. Alexander SPH, Mathie A, Peters JA Hydrogen sulphide synthesis S307 14765381, 2011, s1, · DOI
  84. Alexander SPH, Mathie A, Peters JA Inositol phosphate turnover S309 14765381, 2011, s1, · DOI
  85. Alexander SPH, Mathie A, Peters JA 14765381, 2011, s1, Other family members include AC104758.12-5 (FLJ00317 protein Fragment ENSG00000231463), AC139425.3-1 (ENSG00000225577), and AC126339.6-1 (ENSG00000225734). Abbreviations: ARP100, 2-([{1,1′-biphenyl}-4-ylsulfonyl]-[1-methylethoxy]amino)-N-hydroxyacetamide, AZ10417808, 2-([3,4- dichlorophenyl]amino)-1,4-dihydro-6-nitro-4-oxo-N-2-propenyl-8-quinazolinecarboxamide; · DOI
  86. DasGupta S, Murumkar PR, Giridhar R, Yadav MR (2009). Current perspective of TACE inhibitors: a review. Bioorg Med Chem 17: 444-459.
  87. Ramos-Fernandez M, Bellolio MF, Stead LG (2011). Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review. J Stroke Cerebrovasc Dis 20: 47-54.

Cited by

Sorted by citations

Related

Authors
Alexander, S., Mathie, A., & Peters, J.
Affiliations
  • University of Nottingham (GB)
  • Medway School of Pharmacy (GB)
  • University of Dundee (GB)
ORCID
Mathie, A
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2011-11
Volume
164
Issue
s1
Pages
S1-324
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
DOI
10.1111/j.1476-5381.2011.01649_1.x
PMC
PMC3315626
OpenAlex
W2069380892
Cited by
1,947
References
2
Citations by year
2026: 4 · 2025: 13 · 2024: 12 · 2023: 14 · 2022: 23 · 2021: 19 · 2020: 20 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 47 · 2015: 59 · 2014: 71 · 2013: 191 · 2012: 279
FWCI
109.61
Type
journal article
Language
en
Open access
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations
  • British Journal of Pharmacology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion)
  • Kent Academic Repository (University of Kent) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
therapeutic target, G protein-coupled receptors, ligand-gated ion channels, ion channels, nuclear receptors, transporters, enzymes, receptor nomenclature, pharmacological tools
MeSH terms
Animals, Humans, Ion Channels, Receptors, Cell Surface, Receptors, Cytoplasmic and Nuclear

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review